Digitalizing Cell And Gene Therapy Manufacturing

MES solutions can remove paper from the manufacturing floor once and for all — while boosting operational efficiency and saving costs

• Standard paper-based approaches were being used at four Cell & Gene Therapy (CGT) manufacturing sites
• In a phase-by-phase deployment project, each of these sites implemented the MODA-ES^® Platform to digitalize manufacturing
• The MES system replaced manual data entry, making the chain of custody more reliable
• By adopting digitalization, these sites are now able to provide near-real-time updates to all stakeholders and coordinate logistical activities with ease

This case study walks the challenge, solution and results to manage the operational complexity of CGT manufacturing.